US › Healthcare

NeOnc Technologies Holdings, Inc. Common Stock (NTHI)

US · Healthcare · Biotechnology

$3.41+14.05%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

Net profit

$-14.2M

EPS

$-0.58

EPS estimate

$-0.16

EPS came in at -0.58 against a street estimate of -0.16 — a miss of 262.5%.

Key statistics

Market cap

$106.0M

Forward P/E

0.0

P/B

0.00

Book value

$-0.87

EPS (TTM)

$-2.12

52-week high

$12.99

52-week low

$3.00

50-day MA

$4.06

200-day MA

$6.48

Analyst view

with an average price target of $16.00.

Shareholding

Insiders

53.04%

Institutions

10.98%

Largest institutional holders

Fund	Stake
Cinctive Capital Management LP	6.57%
Bank of America Corp	1.09%
Vanguard Capital Management, LLC	0.99%
Westmount Partners, LLC	0.91%
BlackRock Inc	0.72%
Geode Capital Management, LLC	0.58%
Susquehanna International Group, LLP	0.42%
Vanguard Fiduciary Trust Co	0.26%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for NeOnc Technologies Holdings, Inc. Common Stock — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.